Celldex Therapeutics, Inc. ( CLDX) - Stock Earnings
CLDX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -56.6 million USD | 730000 USD |
| 2025Q3 | -67.0 million USD | — USD |
| 2025Q4 | -81.4 million USD | 75000 USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
CLDX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -141.4 million USD | 6.9 million USD |
| 2024 | -157.9 million USD | 7.0 million USD |
| 2025 | -258.8 million USD | 1.5 million USD |
| 2026 Est. | — | — |
CLDX
Price: $32.12
52 week price:
Earnings Per Share: -3.90 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 345800
Ebitda: -30.7 millionMarket Capitalization: 2.0 billion